1-(Bromomethyl)-2-chloro-4-fluorobenzene → 1-(2-Chloro-4-fluorobenzyl)-2-cyclooctyl-4,4-dimethyl-1,2-diazetidin-3-one
Reaction equation
[CH:1]1([N:9]2[C:12](=[O:13])[C:11]([CH3:15])([CH3:14])[NH:10]2)[CH2:8][CH2:7][CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.[Cl:16][C:17]1[CH:24]=[C:23]([F:25])[CH:22]=[CH:21][C:18]=1[CH2:19]Br>>[Cl:16][C:17]1[CH:24]=[C:23]([F:25])[CH:22]=[CH:21][C:18]=1[CH2:19][N:10]1[C:11]([CH3:15])([CH3:14])[C:12](=[O:13])[N:9]1[CH:1]1[CH2:8][CH2:7][CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1Participants
3
Procedure
2-Cyclooctyl-4,4-dimethyl-1,2-diazetidin-3-one and 2-chloro-4-fluorobenzyl bromide were used for a similar reaction and treatment as Process 6 of Example 1, and the title compound was obtained as a colorless crystalline powder.
Sources & evidence
- ORD record
- ord-3756b5694dea4eef87ed49b4a2f5de74
- Source dataset
- uspto-grants-2012_08
- Patent number
- US08252781B2
Reaction notes
Loading…